Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 1 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Recs

0
Player Avatar pkberneburg (86.07) Submitted: 10/19/2006 9:07:21 AM : Outperform Start Price: $19.50 REGN Score: +574.96

Small-cap biotech should perform through mid-year 2007

Featured Broker Partners


Advertisement